Concurrent downregulation of several TLR genes and upregulation of downstream genes such as MYD88 in breast tumor versus non-tumor tissues may signify negative regulatory feedback subsequent to stimulation by tumor-associated microbial products [36]. The gene discussed is MYD88; the disease is neoplasm.